← Back to all trials
Completed
NCT05200065
Thulium Laser Versus Bipolar Enucleation of the Prostate
Conditions: Benign Prostatic Hyperplasia
Sex: Male
Healthy volunteers: Yes
Phase: NA
Enrollment: 60
Sponsor: Cairo University
Location: Kasr AlAiny School of Medicine Cairo Cairo Governorate
Summary
Comparing the peri-operative outcomes in patients with benign prostatic hyperplasia (BPH) who will undergo bipolar enucleation of the prostate versus thulium laser enucleation.
Eligibility Criteria
Inclusion Criteria:
1. Patients with BPH who are unsatisfied with medical treatment having a Qmax of less than 15 cm/s.
2. Patients with BPH who had refractory retention.
3. Patients with complicated BPH (eg; chronic retention, refractory hematuria, bladder stones).
4. Prostate size of at least 80 grams or more.
Exclusion Criteria:
1. Patients with a bladder mass.
2. Patients with prostate cancer.
3. Patients suffering from a urethral stricture.
4. Patients with previous endoscopic or surgical prostate intervention.
5. Prostate size less than 80 grams.
Source: ClinicalTrials.gov (NCT05200065). StuddyBuddy aggregates publicly available trial information.